Imagyn Medical Technologies Inc.: The Newport Beach...

Imagyn Medical Technologies Inc.: The Newport Beach maker of medical products said it lost $14.8 million, or 42 cents a share, for the second fiscal quarter, which included $5.4 million in restructuring charges and $3.7 million in acquisition costs. That compared with a net loss of $31.4 million, or $1.04 a share, for the corresponding quarter last year, which included $4 million in restructuring charges and a $25.5-million write-off of purchased research and development. Sales for the quarter ended Sept. 30 increased 77% to $43.1 million from $24.3 million. The first half net loss was $29.6 million, or 84 cents a share, compared with a net loss of $36.3 million, or $1.37 a share, for the like six months of the prior year. Sales gained 57% to $69.5 million from $44.2 million.